RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $126

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and raises the price target from $123 to $126.